CSF1 and Alzheimer disease: In addition to the potential implications for AD, an abnormal balance in IL34 and CSF1 signaling has been demonstrated in several neurodegenerative diseases, including Huntington’s, multiple sclerosis, amyotrophic lateral sclerosis, and chronic neuropathic pain58–62.